REFIRE shifts HK$200.00 million and RMB100.00 million of unspent IPO and subscription funds to working capital

Bulletin Express
04/24

Shanghai REFIRE Group Limited (REFIRE) plans to reallocate significant portions of its unutilised fundraising proceeds to bolster day-to-day liquidity, according to a board proposal released on 24 April 2026.

The company raised HK$623.30 million from its November 2024 Hong Kong listing. As of 31 March 2026, HK$321.30 million had been deployed, leaving HK$302.00 million unspent. Management now proposes to redirect HK$200.00 million (66.2 % of the remaining balance) from R&D and production-expansion budgets to working-capital and general corporate purposes. Planned spending on hydrogen fuel-cell component capacity and overseas market expansion would absorb the balance of HK$102.00 million, down sharply from the previous HK$302.00 million allocation.

REFIRE also completed domestic share subscriptions in 2025, generating RMB272.20 million. Usage to 31 March 2026 totalled RMB100.30 million, leaving RMB171.90 million unused. The board seeks to divert RMB100.00 million (58.2 % of the remainder) away from the construction of a hydrogen R&D centre toward working capital. Post-adjustment, only RMB1.30 million (0.8 %) is earmarked for the centre, while RMB70.60 million (41.0 %) will continue funding hydrogen-related R&D.

Directors cite evolving market conditions and a need to “enhance resource utilisation efficiency” as reasons for the reallocations. The proposed changes require shareholder approval via ordinary resolutions at the annual general meeting scheduled for 18 May 2026. If endorsed, all redirected funds are expected to be fully utilised by 31 December 2028.

REFIRE confirmed that its core business focus on hydrogen fuel-cell systems and hydrogen production equipment remains unchanged, and it will disclose progress on fund deployment in future periodic reports.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10